Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,012
datasets available to search
ShareScore release 0.9.0
Dataset results
2,012 results for “Kinase”
Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
ClinicalTrials.gov study NCT04742400. IPD Sharing: YES. Countries: 1. Publications: 0.
Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC
ClinicalTrials.gov study NCT03008109. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protei
ClinicalTrials.gov study NCT02530320. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid Tumors
ClinicalTrials.gov study NCT00500903. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04971187. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Participants With Advanced Malignancies
ClinicalTrials.gov study NCT00651664. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Efficacy and Safety of CML-CP Patients Treated With Asciminib Versus Best Available Therapy, Previously Treated With 2 or More Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT04795427. IPD Sharing: YES. Countries: 1. Publications: 0.
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer
ClinicalTrials.gov study NCT03630120. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)
ClinicalTrials.gov study NCT03579966. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cel
ClinicalTrials.gov study NCT06846671. IPD Sharing: YES. Countries: 12. Publications: 0.
Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01034553. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma
ClinicalTrials.gov study NCT01316692. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
ClinicalTrials.gov study NCT04902833. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01478581. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor
ClinicalTrials.gov study NCT03235544. IPD Sharing: YES. Countries: 11. Publications: 0.
Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02521051. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosin
ClinicalTrials.gov study NCT02271139. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.
ClinicalTrials.gov study NCT03224104. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT04329325. IPD Sharing: YES. Countries: 1. Publications: 0.
Expression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases.
ClinicalTrials.gov study NCT04674163. IPD Sharing: Not stated. Countries: 0. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.